A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 78 countries with approximately 64,500 employees and serves more than 3.8 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.
Air Liquide’s ambition is to be a leader in its industry, deliver long term performance and contribute to sustainability - with a strong commitment to climate change and energy transition at the heart of its strategy.
With nearly 13,500 employees, a presence in 35 countries, and a turnover of more than 2.8 billion euros, Air Liquide Healthcare, the Health Division of the Air Liquide Group, is one of the world leaders in this field. Today, Air Liquide Healthcare is present in hospitals and patient homes to provide products, services and support programs for the prevention, diagnosis and treatment of chronic diseases or acute episodes. ALSI (Air Liquide Santé International), the health holding company, has 160 employees.
More than 400 million people are living with diabetes worldwide and are concerned in improving their quality of life. To face the rising cost of healthcare, due to this growing number of patients to treat, Healthcare systems are actively looking to transform their models, to better allocate their budgets and ensure their resilience.
Supporting several thousands people with diabetes for nearly twenty years, Air Liquide Healthcare has a unique opportunity to accelerate its business transformation towards value-based models. Our ambition is to improve the outcomes that matter to People with Diabetes, thanks to personalized care plans, and to be recognised for the value we bring, thanks to clinical & economical evidence. This value transformation is key to ensure the long term sustainability of our activity, as diabetes represents a key booster of Home Healthcare growth.
Reporting to the Diabetes Program Director, the employee will lead one of the two strategic streams of the Diabetes Program and will work closely with all members of the Program team, the Market Access & Evidence team, the Patient Centricity team, and the Partnerships team to ensure a successful outcome.
He/she will call on the expertise of the Legal, Digital & IT, and Procurement & Explor! center teams when necessary. He/she will work closely with the clusters and subsidiaries concerned by his/her scope.
The above mentioned strategic stream include the following objectives:
- Define with all stakeholders and drive the implementation of its stream priorities
- Analyze market needs and identify new offers or opportunities that will establish our existing businesses, from the detection of the need to the operational deployment plan, including the business plan
- Conduct pilots in key countries if necessary
- Follow the key indicators related to the implementation of new offers
Master’s Degree
Knowledge of Diabetes and Diabetes Market mandatory
Fluent English required
Knowledge of Google tools
We are looking for someone who has a good sense of organization, who is rigorous, autonomous, and a great team player.
Geographical location: 92-Bagneux
National collective agreement: Chemistry
Inscrivez-vous pour accéder à l'annonce
Global Marketing Manager Diabetes (H/F)En cliquant ci-dessus sur « S'inscrire » vous accepter nos conditions générales et notre politique de confidentialité
1er Site de recherche d'emplois dédié aux professionnels du marketing de la communication et du digital, Jobibou.com a pour objectif de vous offrir le meilleur outil de recherche pour vous accompagner, au mieux, dans votre démarche de recherche d'emploi
Inscrivez-vous pour accéder à l'annonce
Global Marketing Manager Diabetes (H/F)Merci de bien vouloir remplir le formulaire pour profiter de l’ensemble des fonctionnalités Jobibou !
Déjà inscrit ? Se connecter